Evidence status: CURRENT PROFESSIONAL RULE REFRESH RECORD. Several New Hampshire professional boards have recently readopted or updated their opioid-prescribing rules, confirming that the treatment-agreement framework remains active rather than merely historical.

Dentistry — March 7, 2025

The Board of Dental Examiners renumbered and readopted its opioid-prescribing provisions effective March 7, 2025. Den 503.04 continues to require a written chronic-pain treatment agreement with the core state subjects.

Optometry — August 2, 2025

Optometry’s opioid-prescribing chapter was readopted with amendments effective August 2, 2025. Opt 502.04 continues to require the written treatment agreement, twice-yearly treatment review, at-least-annual random urine testing after 90 days, and the narrow nursing-home/episodic-pain exemptions.

Podiatry — July 1, 2026

Podiatry’s updated opioid-prescribing rules became effective July 1, 2026. Pod 502.05 continues the same basic chronic-pain agreement structure: written agreement in the medical record, one prescriber or practice, safe medication use/storage, periodic/random drug-testing consent, clinical coverage, twice-yearly treatment review, and at-least-annual urine testing after 90 days.

Why this matters

The agreement mandate originated in the 2016 statutory rulemaking framework, but current professional boards continue to carry it forward through 2025-2026 rule readoptions. This is current regulation, not an abandoned opioid-era relic.

Primary sources

Reviewed: October 4, 2026.